×
Entrez Id:
4810
Gene Symbol:
NHS
NHS
0.100
GeneticVariation
disease
GWASDB
A genome-wide association study identifies susceptibility loci for Wilms tumor.
22544364
2012
×
Entrez Id:
6948
Gene Symbol:
TCN2
TCN2
0.100
GeneticVariation
disease
GWASDB
A genome-wide association study identifies susceptibility loci for Wilms tumor.
22544364
2012
×
Entrez Id:
255738
Gene Symbol:
PCSK9
PCSK9
0.100
GeneticVariation
disease
GWASDB
A genome-wide association study identifies susceptibility loci for Wilms tumor.
22544364
2012
×
Entrez Id:
1740
Gene Symbol:
DLG2
DLG2
0.100
GeneticVariation
disease
GWASDB
A genome-wide association study identifies susceptibility loci for Wilms tumor.
22544364
2012
×
Entrez Id:
2719
Gene Symbol:
GPC3
GPC3
0.800
Biomarker
disease
GENOMICS_ENGLAND
×
Entrez Id:
7490
Gene Symbol:
WT1
WT1
0.800
Biomarker
disease
GENOMICS_ENGLAND
Genotype-phenotype associations in WT1 glomerulopathy.
24402088
2014
×
Entrez Id:
7490
Gene Symbol:
WT1
WT1
0.800
Biomarker
disease
GENOMICS_ENGLAND
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
23788249
2013
×
Entrez Id:
7490
Gene Symbol:
WT1
WT1
0.800
Biomarker
disease
GENOMICS_ENGLAND
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
0.720
Biomarker
disease
GENOMICS_ENGLAND
Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group.
29661970
2018
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
0.720
Biomarker
disease
GENOMICS_ENGLAND
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
23788249
2013
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
0.720
Biomarker
disease
GENOMICS_ENGLAND
Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.
16825431
2007
×
Entrez Id:
10155
Gene Symbol:
TRIM28
TRIM28
0.620
Biomarker
disease
GENOMICS_ENGLAND
We recommend that all individuals with Wilms tumour should be offered genetic testing and particularly, those with epithelial Wilms tumour should be offered TRIM28 genetic testing.
30885698
2019
×
Entrez Id:
1028
Gene Symbol:
CDKN1C
CDKN1C
0.480
Biomarker
disease
GENOMICS_ENGLAND
CDKN1C expression in Beckwith-Wiedemann syndrome patients with allele imbalance.
10424812
1999
×
Entrez Id:
7490
Gene Symbol:
WT1
WT1
0.800
GeneticVariation
disease
UNIPROT
The detection of one nonsense point mutation and one missense WT1 gene point mutation adds to the accumulating evidence implicating this gene in a proportion of Wilms tumor patients.
1317572
1992
×
Entrez Id:
7490
Gene Symbol:
WT1
WT1
0.800
GeneticVariation
disease
UNIPROT
Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
9529364
1998
×
Entrez Id:
7490
Gene Symbol:
WT1
WT1
0.800
GeneticVariation
disease
UNIPROT
Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology.
9108089
1997
×
Entrez Id:
7490
Gene Symbol:
WT1
WT1
0.800
GeneticVariation
disease
UNIPROT
Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development.
15150775
2004
×
Entrez Id:
10664
Gene Symbol:
CTCF
CTCF
0.340
GeneticVariation
disease
UNIPROT
×
Entrez Id:
7273
Gene Symbol:
TTN
TTN
0.300
GeneticVariation
disease
UNIPROT
×
Entrez Id:
7428
Gene Symbol:
VHL
VHL
0.510
Biomarker
disease
RGD
By immunohistochemistry, however, VHL protein level was evidently reduced in six of the eight eosinophilic renal epithelial tumors and in all the ten nephroblastomas .
11880179
2002
×
Entrez Id:
5076
Gene Symbol:
PAX2
PAX2
0.300
Biomarker
disease
RGD
A rodent model for Wilms tumors: embryonal kidney neoplasms induced by N-nitroso-N'-methylurea.
7937920
1994
×
Entrez Id:
655
Gene Symbol:
BMP7
BMP7
0.210
Biomarker
disease
RGD
Deficient expression of mRNA for the putative inductive factor bone morphogenetic protein-7 in chemically initiated rat nephroblastomas .
9808158
1998
×
Entrez Id:
2719
Gene Symbol:
GPC3
GPC3
0.800
Biomarker
disease
ORPHANET
These findings imply a possible role for GPC3 in Wilms' tumour development.
12085187
2002
×
Entrez Id:
2719
Gene Symbol:
GPC3
GPC3
0.800
Biomarker
disease
ORPHANET
The GPC3 gene product in Wilms tumor was further evaluated by immunohistochemistry and quantified by an automated image analysis.
25366870
2015
×
Entrez Id:
7490
Gene Symbol:
WT1
WT1
0.800
SusceptibilityMutation
disease
ORPHANET